EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults

Wolfgang H Jost iD, Petr Kaňovský iD, Michael A Hast, Angelika Hanschmann, Michael Althaus, Atul T Patel iD

Toxins · 23.05.2023 · 15 (6) · 353

DOI: 10.3390/toxins15060353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, online erschienen am 23.05.2023. Verfasst von Wolfgang H Jost und 5 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson-Klinik Ortenau, 77709 Wolfach, Germany. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Deglutition Disorders, Nervous System Diseases, Neuromuscular Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merz Pharmaceuticals, LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pooled incidences of treatment-emergent adverse events (TEAEs) were examined by indication using the integrated clinical database of Merz-sponsored, placebo-controlled, or repeat-dose studies of incobotulinumtoxinA in adults with cervical dystonia, blepharospasm, limb spasticity, sialorrhea, or essential tremor of the upper limb. Overall incidences of TEAEs, serious TEAEs, TEAEs leading to discontinuation, fatal TEAEs, TEAEs of special interest (TEAESIs; indicating possible toxin spread), and treatment-related (TR) events were determined for incobotulinumtoxinA and placebo after a single injection and for repeated dose cycles of incobotulinumtoxinA. The most frequent events after a single dose of incobotulinumtoxinA are summarized. After a single cycle, incidences of overall TEAEs were similar between incobotulinumtoxinA and the placebo in most indications, although between-indication differences were observed. Few TEAEs led to incobotulinumtoxinA discontinuation; there were no fatal TEAEs with incobotulinumtoxinA. In general, repeated cycles did not increase the incidence of any event. The most frequent TR-TEAEs were indication-dependent, including dysphagia for indications affecting the head or neck. The TR-TEAESIs across all indications were most commonly muscular weakness, dysphagia and dry mouth. Overall, the results of this pooled analysis support and extend the favorable safety and tolerability profile of incobotulinumtoxinA for the treatment of adult neurological disorders established by individual clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ADeglutition DisordersNervous System DiseasesNeuromuscular AgentsTorticollisAdultHumansDouble-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

blepharospasmcervical dystoniaessential tremorimmunogenicityincobotulinumtoxinAmotor disordersneurological disorderssafetysialorrheaspasticity

Substanzen

Botulinum Toxins, Type AincobotulinumtoxinANeuromuscular Agents

Autor:innen und Institutionen

  • Parkinson-Klinik Ortenau, 77709 Wolfach, Germany.
  • Faculty of Medicine and Dentistry and University Hospital, Palacký University Olomouc, 779 00 Olomouc, Czech Republic.
  • Merz Pharmaceuticals, LLC, Raleigh, NC 27615, USA.
  • Merz Therapeutics GmbH, 60318 Frankfurt am Main, Germany.
  • Kansas City Bone and Joint Clinic, Overland Park, KS 66211, USA.

ORCID-Profile: Wolfgang H Jost, Petr Kaňovský, Atul T Patel

Förderung

  • Merz Pharmaceuticals, LLC

Zitieren

APA

Jost, W. H., Kaňovský, P., Hast, M. A., Hanschmann, A., Althaus, M., & Patel, A. T. (2023). Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults. Toxins, 15(6), 353. https://doi.org/10.3390/toxins15060353

Vancouver

Jost WH, Kaňovský P, Hast MA, Hanschmann A, Althaus M, Patel AT. Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults. Toxins. 2023;15(6):353. doi:10.3390/toxins15060353

BibTeX
@article{Jost2023,
  author = {Jost, Wolfgang H and Kaňovský, Petr and Hast, Michael A and Hanschmann, Angelika and Althaus, Michael and Patel, Atul T},
  title = {Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults},
  journal = {Toxins},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {353},
  doi = {10.3390/toxins15060353}
}
Kostenlos starten →